Cancer
HER2-targeted drugs (trastuzumab)
Antibodies and kinase inhibitors aimed at the HER2 receptor, overexpressed in about a fifth of breast cancers; trastuzumab greatly improves survival in HER2-positive disease, with a risk of reversible heart dysfunction.
طریقۂ عمل
- In HER2-positive breast cancer, amplified HER2 receptors signal constantly for growth.
- Trastuzumab binds HER2, blocks its signalling and marks the cells for antibody-dependent cell-mediated killing; pertuzumab blocks HER2 pairing with HER3.
- Trastuzumab deruxtecan carries a cytotoxic drug into the HER2-positive cell; lapatinib and tucatinib block the HER2 kinase inside the cell.
- HER2 also protects heart muscle cells under stress, explaining the cardiotoxicity.
Molecular targets
- HER2 (ERBB2) receptor: Blocking antibody or kinase inhibitor
HER2-targeted drugs (trastuzumab) کی ادویات
Monoclonal antibodies
- Trastuzumab (Intravenous or subcutaneous.)
- Pertuzumab (With trastuzumab.)
Antibody–drug conjugate
- Trastuzumab deruxtecan (Antibody–drug conjugate.)
Tyrosine kinase inhibitors
- Lapatinib and tucatinib (Kinase inhibitors, by mouth.)
علاج میں استعمال
- HER2-positive breast cancer: before or after surgery, and in metastatic disease
- HER2-positive gastric cancer (trastuzumab with chemotherapy)
جن بیماریوں کا علاج کرتی ہے
مضر اثرات
- Reduced left ventricular function and heart failure, usually reversible
- Infusion reactions
- Interstitial lung disease (trastuzumab deruxtecan)
حالت کے لحاظ سے ممانعت
- Myocardial infarction (احتیاط سے): HER2 blockade impairs the stressed heart muscle.
- Given with anthracyclines (احتیاط سے): Cardiotoxicity adds up; they are usually given in sequence.
- Pregnancy (ممنوع): It reduces amniotic fluid (oligohydramnios) and harms the fetus.
دیگر احتیاطیں اور interactions
- Only HER2-positive tumours (by immunohistochemistry or gene amplification) benefit.
- Heart function is checked before and during treatment.
جڑے ہوئے موضوعات
ماخذ
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 35, Anticancer Drugs, Monoclonal antibodies: trastuzumab
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 54, Cancer Chemotherapy, HER2 inhibitors
تعلیمی حوالہ۔ طبی مشورہ، تشخیص یا علاج نہیں۔